Ditchcarbon
  • Customers
  1. Organizations
  2. Sanofi
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 6 days ago

Sanofi

Company website

Sanofi, a global healthcare leader headquartered in France, is renowned for its commitment to improving health and well-being. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Operating within the pharmaceutical and biotechnology industry, Sanofi focuses on several main business areas, including prescription medicines, vaccines, and consumer healthcare products. Its core offerings, such as innovative treatments for diabetes, rare diseases, and vaccines, are distinguished by their scientific rigor and patient-centric approach. With a robust market position, Sanofi has achieved notable milestones, including advancements in immunology and oncology, solidifying its reputation as a trusted name in global health solutions.

DitchCarbon Score

How does Sanofi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Sanofi's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Sanofi's reported carbon emissions

In 2024, Sanofi reported total greenhouse gas emissions of approximately 4,196,976,000 kg CO2e, with Scope 1 emissions at about 298,485,000 kg CO2e, Scope 2 emissions (market-based) at approximately 75,864,000 kg CO2e, and Scope 3 emissions reaching about 3,822,627,000 kg CO2e. The company has set ambitious targets to reduce its carbon footprint, aiming for a 55% reduction in absolute Scope 1 and 2 emissions by 2030, compared to a 2019 baseline. Additionally, Sanofi is committed to achieving net-zero emissions across its value chain by 2045. In 2023, Sanofi's global emissions were approximately 4,448,234,000 kg CO2e, with Scope 1 emissions at about 332,470,000 kg CO2e and Scope 2 emissions (market-based) at approximately 90,752,000 kg CO2e. The company also disclosed significant Scope 3 emissions of around 4,025,012,000 kg CO2e. Sanofi's climate commitments include increasing its sourcing of renewable electricity from 11% in 2019 to 80% by 2025 and achieving 100% by 2030. Furthermore, the company aims to reduce its Scope 3 emissions by 30% by 2030, focusing on areas such as purchased goods and services, capital goods, and waste generated in operations. These targets have been validated by the Science Based Targets initiative (SBTi), reinforcing Sanofi's commitment to align with global climate goals and limit warming to 1.5°C. The company is on track to meet its near-term targets, with a long-term goal of reducing total emissions (Scopes 1, 2, and 3) by 90% by 2045, using 2019 as the baseline year.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20102011201220132014201920202021202220232024
Scope 1
545,114,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
677,549,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sanofi's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sanofi is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sanofi is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Wockhardt

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Piramal Enterprises Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Bayer

DE
•
Chemicals nec
Updated about 6 hours ago

GlaxoSmithKline Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy